Aurobindo Pharma Ltd has posted a consolidated net profit of Rs 18.6 crore in the first quarter ended June 30, 2013.
In the corresponding quarter of the previous financial year, the Hyderabad-based firm suffered a net loss of Rs 129 crore. Revenues increased to Rs 1,699 crore (Rs 1,197 crore).
“Our focus on costs and the qualitative aspect of sales across key markets have reflected positively on our revenues and operating margins on a year-on-year basis,’’ Aurobindo Pharma Managing Director N. Govindarajan said in a release.
The net profit was impacted by the mark-to-market component of its dollar-denominated debt because of the rupee depreciation during the quarter, he added.